Matthew Davies, Anne Christopher, John Edwards, Roland Kent, Andrew Trobridge, Marcel Dreischarf, Rachelle Yusufbekov, Timothy Beacham
{"title":"双体体SI关节融合系统下-后路骶髂关节融合术后12个月的临床和影像学结果:一项前瞻性、多中心评估","authors":"Matthew Davies, Anne Christopher, John Edwards, Roland Kent, Andrew Trobridge, Marcel Dreischarf, Rachelle Yusufbekov, Timothy Beacham","doi":"10.1080/17434440.2025.2544611","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Scientific evidence on novel transarticular inferior-posterior surgical approaches for sacroiliac (SI) joint fusion, designed to minimize the risk of neurovascular injury, remains limited.</p><p><strong>Methods: </strong>This prospective, multi-center study evaluated disability (ODI), SI-joint pain (VAS), and patient satisfaction following SI joint fusion using the inferior-posterior approach. The primary endpoint was composite success, defined as: (1) ≥20 mm VAS pain reduction, (2) no device-related serious adverse events, (3) no neurological worsening, and (4) no surgical reintervention. Fusion was assessed at 12 months via independent radiographic CT review.</p><p><strong>Results: </strong>Thirty-six patients (mean age: 58.9 years; 77.8% female) underwent treatment. At the time of analysis, ODI significantly improved from 51.6% at baseline to 28.0% at 6-month (<i>n</i> = 32) and 20.8% at 12-month (<i>n</i> = 24, all <i>p</i> < 0.001). VAS scores declined from 78.8 mm to 35.6 mm at 6-month (<i>n</i> = 30) and 23.0 mm at 12-month (<i>n</i> = 24, all <i>p</i> < 0.001). Composite success was achieved in 73.3% at 6 month and 87.0% at 12 months (post hoc). Fusion was confirmed in 82.6% of cases, with 83.3% patient satisfaction. No serious device- or procedure-related adverse events or reinterventions were reported.</p><p><strong>Conclusion: </strong>This interim analysis of an ongoing study demonstrates significant improvements in disability and pain, while the novel surgical approach promotes fusion. Although the results are promising, larger studies with longer follow-up are warranted to validate these findings.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"1117-1125"},"PeriodicalIF":2.7000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Twelve-month clinical and radiographic outcomes following inferior-posterior sacroiliac joint fusion using the Catamaran SI Joint Fusion System: a prospective, multi-center evaluation.\",\"authors\":\"Matthew Davies, Anne Christopher, John Edwards, Roland Kent, Andrew Trobridge, Marcel Dreischarf, Rachelle Yusufbekov, Timothy Beacham\",\"doi\":\"10.1080/17434440.2025.2544611\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Scientific evidence on novel transarticular inferior-posterior surgical approaches for sacroiliac (SI) joint fusion, designed to minimize the risk of neurovascular injury, remains limited.</p><p><strong>Methods: </strong>This prospective, multi-center study evaluated disability (ODI), SI-joint pain (VAS), and patient satisfaction following SI joint fusion using the inferior-posterior approach. The primary endpoint was composite success, defined as: (1) ≥20 mm VAS pain reduction, (2) no device-related serious adverse events, (3) no neurological worsening, and (4) no surgical reintervention. Fusion was assessed at 12 months via independent radiographic CT review.</p><p><strong>Results: </strong>Thirty-six patients (mean age: 58.9 years; 77.8% female) underwent treatment. At the time of analysis, ODI significantly improved from 51.6% at baseline to 28.0% at 6-month (<i>n</i> = 32) and 20.8% at 12-month (<i>n</i> = 24, all <i>p</i> < 0.001). VAS scores declined from 78.8 mm to 35.6 mm at 6-month (<i>n</i> = 30) and 23.0 mm at 12-month (<i>n</i> = 24, all <i>p</i> < 0.001). Composite success was achieved in 73.3% at 6 month and 87.0% at 12 months (post hoc). Fusion was confirmed in 82.6% of cases, with 83.3% patient satisfaction. No serious device- or procedure-related adverse events or reinterventions were reported.</p><p><strong>Conclusion: </strong>This interim analysis of an ongoing study demonstrates significant improvements in disability and pain, while the novel surgical approach promotes fusion. Although the results are promising, larger studies with longer follow-up are warranted to validate these findings.</p>\",\"PeriodicalId\":94006,\"journal\":{\"name\":\"Expert review of medical devices\",\"volume\":\" \",\"pages\":\"1117-1125\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert review of medical devices\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/17434440.2025.2544611\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert review of medical devices","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17434440.2025.2544611","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:旨在将神经血管损伤风险降至最低的新型经关节下后路骶髂关节融合术的科学证据仍然有限。方法:这项前瞻性、多中心研究评估了下后路SI关节融合术后的残疾(ODI)、SI关节疼痛(VAS)和患者满意度。主要终点是综合成功,定义为:(1)≥20mm VAS疼痛减轻,(2)无器械相关的严重不良事件,(3)无神经系统恶化,(4)无手术再干预。12个月时通过独立的x线CT检查评估融合情况。结果:36例患者,平均年龄58.9岁;77.8%女性)接受治疗。在分析时,ODI从基线时的51.6%显著改善到6个月时的28.0% (n = 32)和12个月时的20.8% (n = 24,所有p n = 30)和12个月时的23.0 mm (n = 24,所有p)。结论:这项正在进行的研究的中期分析表明,残疾和疼痛有显著改善,而新的手术入路促进融合。虽然结果很有希望,但有必要进行更大规模的长期随访研究来验证这些发现。
Twelve-month clinical and radiographic outcomes following inferior-posterior sacroiliac joint fusion using the Catamaran SI Joint Fusion System: a prospective, multi-center evaluation.
Background: Scientific evidence on novel transarticular inferior-posterior surgical approaches for sacroiliac (SI) joint fusion, designed to minimize the risk of neurovascular injury, remains limited.
Methods: This prospective, multi-center study evaluated disability (ODI), SI-joint pain (VAS), and patient satisfaction following SI joint fusion using the inferior-posterior approach. The primary endpoint was composite success, defined as: (1) ≥20 mm VAS pain reduction, (2) no device-related serious adverse events, (3) no neurological worsening, and (4) no surgical reintervention. Fusion was assessed at 12 months via independent radiographic CT review.
Results: Thirty-six patients (mean age: 58.9 years; 77.8% female) underwent treatment. At the time of analysis, ODI significantly improved from 51.6% at baseline to 28.0% at 6-month (n = 32) and 20.8% at 12-month (n = 24, all p < 0.001). VAS scores declined from 78.8 mm to 35.6 mm at 6-month (n = 30) and 23.0 mm at 12-month (n = 24, all p < 0.001). Composite success was achieved in 73.3% at 6 month and 87.0% at 12 months (post hoc). Fusion was confirmed in 82.6% of cases, with 83.3% patient satisfaction. No serious device- or procedure-related adverse events or reinterventions were reported.
Conclusion: This interim analysis of an ongoing study demonstrates significant improvements in disability and pain, while the novel surgical approach promotes fusion. Although the results are promising, larger studies with longer follow-up are warranted to validate these findings.